Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1
Quanxiang Liu1, Yang Song1, Xianliang Duan1
1Department of Orthopedics, The Affiliated Hospital of Beihua University, Jilin, China.
Background:
MicroRNAs (miRs) have been implicated in the development and progression of osteosarcoma. Here, we aimed to illustrate the important role of miR-92a on the regulation of OS development which may help to establish a novel strategy for OS diagnosis and treatment.
Materials And Methods:
Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell cycle and apoptosis were assessed by flow cytometry with PI and PI/Annexin-V stain, respectively. The expression of proteins was examined by western blot. qPCR was used to detect the expression of RNA. Cell migration was assayed with transwell assay.
Results:
MiR-92a inhibited the proliferation and the migration of OS in vitro and reduced the volume of the tumour in vivo. Further, miR-92a enhanced cisplatin sensitivity of OS. MiR-92a directly targeted Notch1.
Conclusion:
Together, our results indicate that miR-92a inhibited cell growth, migration, and enhanced cisplatin sensitivity of OS cell by targeting Notch1.
Insights
MicroRNA-92a (miR-92a) inhibits osteosarcoma (OS) growth and migration by targeting Notch1. This finding offers a potential new strategy for OS diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRs) play a role in osteosarcoma (OS) development and progression.
- Investigating specific miRs like miR-92a is crucial for understanding OS pathogenesis.
- This study focuses on miR-92a's regulatory function in OS.
Purpose of the Study:
- To elucidate the role of miR-92a in osteosarcoma (OS) development.
- To explore miR-92a as a potential diagnostic and therapeutic target for OS.
- To identify the molecular mechanisms underlying miR-92a's function in OS.
Main Methods:
- Cell viability assessed using MTT assay.
- Cell cycle and apoptosis analyzed by flow cytometry.
- Protein expression evaluated via Western blot; RNA expression by qPCR; cell migration using Transwell assay.
Main Results:
- MiR-92a inhibited osteosarcoma (OS) cell proliferation and migration in vitro.
- MiR-92a reduced tumor volume in vivo and enhanced cisplatin sensitivity in OS.
- MiR-92a was identified as a direct target of Notch1.
Conclusions:
- MiR-92a inhibits OS cell growth and migration through Notch1.
- MiR-92a enhances cisplatin sensitivity in osteosarcoma (OS) cells.
- Targeting miR-92a presents a novel therapeutic strategy for osteosarcoma (OS).
More Related Videos
11:00Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Related Concept Videos
Feedback Inhibition
Increasing Function
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Enzyme Inhibition